During the past decade, Monash Alfred Psychiatry Research Centre conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Monash Alfred Psychiatry Research Centre" #1 sponsor was "The Alfred" with 8 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Bayside Health" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Anavex Life Sciences Corp." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Monash Alfred Psychiatry Research Centre" #1 collaborator was "Monash University" with 3 trials as a collaborator, "Anavex Australia Pty Ltd." with 1 trials as a collaborator, "Anavex Canada Ltd." with 1 trials as a collaborator, "Anavex Germany GmbH" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Monash Alfred Psychiatry Research Centre" are "Schizophrenia" (6 trials), "Major Depressive Disorder" (4 trials), "Borderline Personality Disorder" (2 trials), "Schizoaffective Disorder" (2 trials) and "Smoking Cessation" (2 trials). Many other conditions were trialed in "Monash Alfred Psychiatry Research Centre" in a lesser frequency.

Most popular intervention types in "Monash Alfred Psychiatry Research Centre" are "Drug" (12 trials), "Device" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Transcranial Magnetic Stimulation" (3 trials), "BI 1358894" (2 trials), "Nicotine Replacement Therapy Patch" (2 trials) and "Raloxifene hydrochloride" (2 trials). Other intervention names were less common.

The vast majority of trials in "Monash Alfred Psychiatry Research Centre" are 13 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Monash Alfred Psychiatry Research Centre". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Monash Alfred Psychiatry Research Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Monash Alfred Psychiatry Research Centre, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 5 trials that are defined as “Not Applicable".